Results 101 to 110 of about 43,190 (248)

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

New England Journal of Medicine, 2018
Background Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy. Methods In this randomized,
A. Spyropoulos, W. Ageno, G. Albers, G. Elliott, J. Halperin, W. Hiatt, G. Maynard, G. Steg, J. Weitz, E. Suh, T. Spiro, E. Barnathan, G. Raskob   +12 more
semanticscholar   +1 more source

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

Blood Advances, 2020
Anticoagulant treatment of pediatric cerebral venous thrombosis has not been evaluated in randomized trials. We evaluated the safety and efficacy of rivaroxaban and standard anticoagulants in the predefined subgroup of children with cerebral venous ...
P. Connor, M. Sánchez van Kammen, A. Lensing, E. Chalmers, K. Kállay, Kerry M Hege, P. Simioni, T. Biss, F. Bajolle, D. Bonnet, S. Grunt, Riten Kumar, O. Lvova, R. Bhat, An Van Damme, J. Palumbo, A. Santamaría, P. Saracco, J. Payne, S. Baird, K. Godder, V. Labarque, C. Male, I. Martinelli, Michelle Morales Soto, J. Motwani, Sanjay Shah, H. L. Hooimeijer, M. Prins, D. Kubitza, William T. Smith, S. Berkowitz, Á. Pap, Madhurima Majumder, P. Monagle, J. Coutinho   +35 more
semanticscholar   +1 more source

Apixaban in patients with nonvalvular atrial fibrillation, heart failure and low body weight: A report from a global federated research dataset

European Journal of Clinical Investigation, Volume 55, Issue 5, May 2025.
In a cohort of 155,152 patients with atrial fibrillation, heart failure and low body weight, patients weighting <60 kg faced a higher risk of adverse events compared to those in the reference BW (60–100 kg), regardless of treatment. Apixaban demonstrated a lower risk of ischaemic stroke/systemic embolism, bleedings (including intracranial hemorrhage ...
Luca Monzo, Guillaume Baudry, Gema Hernandez, Olivier Denquin, Gianluigi Savarese, Gregory Y. H. Lip, Nicolas Girerd   +6 more
wiley   +1 more source

Carbon Dioxide Digital Subtraction Angiography for Central Venous Recanalization in a Kidney Transplant Patient: A Case Report

Hemodialysis International, EarlyView.
ABSTRACT Background We present the case of a kidney transplant recipient with elevated serum creatinine who developed left upper limb swelling due to left subclavian vein thrombosis. Concerned about potential hemodialysis resumption, the patient prioritized preserving their arteriovenous fistula.
Limei Chen, Ruining Liu, Tianlei Cui
wiley   +1 more source

Rivaroxaban-Associated Bullous Pemphigoid in a Patient With Atrial Fibrillation

CJC Open, 2021
Rivaroxaban is commonly used for prevention of thromboembolic diseases in patients with atrial fibrillation. We report a case of an 86-year-old man with hypertension, chronic kidney disease, type 2 diabetes mellitus, dyslipidemia, and atrial fibrillation
Jiaming (Calvin) Liang, MD, MSc, Karanvir Raman, BBA, Siu Him Chan, MD, A. Yashar Tashakkor, MD   +3 more
doaj  

Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation

TH Open, 2018
Rivaroxaban and apixaban are both small molecules that reversibly inhibit factor Xa. Compared with rivaroxaban, apixaban has minimal effects on the prothrombin time and activated partial thromboplastin time.
Paul Y. Kim, Calvin H. Yeh, Brian J. Dale, Beverly A. Leslie, Alan R. Stafford, James C. Fredenburgh, Jack Hirsh, Jeffrey I. Weitz   +7 more
doaj   +1 more source

Postoperative TIPS Reaction in a Patient With Portal Vein Dysfunction

Portal Hypertension &Cirrhosis, EarlyView.
Qihao Du, Jiaming Lan, Ke Xu, Meng Niu
wiley   +1 more source

Do antithrombotic drugs have a role in migraine prevention? A systematic review

Headache: The Journal of Head and Face Pain, Volume 65, Issue 4, Page 709-727, April 2025.
Abstract Objectives To explore the available evidence on the role of antithrombotics as migraine preventive medication. Background In clinical practice, the use of antithrombotic drugs in individuals with migraine is sometimes considered, especially in the case of frequent auras, association with patent foramen ovale, or prothrombotic states.
Federico De Santis, Matteo Foschi, Michele Romoli, Vincenzo Mastrangelo, Chiara Rosignoli, Agnese Onofri, Simona Sacco, Raffaele Ornello   +7 more
wiley   +1 more source

Physiologically‐Based Pharmacokinetic Modeling for the Prediction of a Drug–Drug Interaction of Combined Effects on P‐glycoprotein and Cytochrome P450 3A

CPT: Pharmacometrics & Systems Pharmacology, 2020
Direct oral anticoagulants, such as apixaban and rivaroxaban, are important for the treatment and prophylaxis of venous thromboembolism and to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
Yukio Otsuka, Mary P. Choules, Peter L. Bonate, Kanji Komatsu   +3 more
doaj   +1 more source

Activated Protein C Resistance Testing: An Update From Australasia/Asia‐Pacific

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Activated protein C resistance (APCR) represents a risk factor for thrombosis and is usually due to factor V Leiden (FVL). Clinicians may order either test (i.e., APCR or FVL) to help assess ‘thrombophilia’ in patients who present with thrombosis. APCR testing is usually achieved using clot‐based assays, whereas FVL is assessed by
Emmanuel J. Favaloro, Sandya Arunachalam, Elysse Dean, Mahzuza Salwa, Monica Ahuja, Lynne Connelly, Kent Chapman, Ronny Vong, Leonardo Pasalic   +8 more
wiley   +1 more source